Recently, Zhang et al. found that androgen/AR signaling dampens T-cell-mediated immunity in males by upregulating ubiquitin-specific protease 18 expression, which in turn inhibits TGFβ-activated kinase 1 phosphorylation and the activation of NF-κB in anti-tumor T cells [130]. Here, AR is linked to neoplasm.